← Open Payments lookup

AMANDA FOSTER: Open Payments

NPI 1891473690 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,096 in 205 payments from 23 companies in 2025. Trend: 2023 $925 · 2024 $3,550 · 2025 $4,096

Food & beverage: $3,717Education: $379
CompanyPaymentsAmount
Calliditas Therapeutics US Inc.23$528
Novartis Pharmaceuticals Corporation24$478
OPKO Pharmaceuticals, LLC25$379
Fresenius USA Marketing, Inc.20$373
Travere Therapeutics, Inc.11$310
AstraZeneca Pharmaceuticals LP12$308
Amgen Inc.17$280
Mallinckrodt Hospital Products Inc.14$249
Bayer Healthcare Pharmaceuticals Inc.12$215
Otsuka America Pharmaceutical, Inc.9$209

Products named: TARPEYO, Fabhalta, RAYALDEE, VELPHORO, ACTHAR, Kerendia, LOKELMA, JARDIANCE.

Industry payments across LA — which companies pay providers there.